.png)
Infrastructure
The manufacturing operations of Precise are done in world-class manufacturing facilities in India. Precise is vertically integrated, with production facilities for APIs, Formulations, Intermediates enabling an efficient supply chain and ensuring quality control and cost.
WHO-GMP Certified
API Manufacturing Units
We have 2 units for multi-product API manufacturing along with a well-equipped R&D facility at Navi-Mumbai. Our manufacturing facility is WHO-GMP Certified.
​
-
Manufacturing operations are carried out in two units in Navi Mumbai.
-
These facilities are operated in accordance with the latest regulatory guidelines.
-
Stainless steel and Glass Lined Reactors of various sizes ranging from 50 liters to 2500 liters capacity.
-
Ability to handle temperature ranging from -15°C to 150°C
-
Zero liquid discharge compliant.
-
State-of-the-art equipment and instruments give us the edge to compete globally.
-
Our network with leading cargo handlers enables us to provide faster service to our customers across the world.
State-of-the-Art
Finished Formulations Unit
Our finished products are manufactured in WHO-GMP/EU Certified manufacturing facilities. We have in-house full fledged Regulatory Department which can cater to requirements of all the regulatory aspects globally.
​
-
State-of-The-Art Manufacturing facility conforming to WHO-GMP / EU Standard
-
Manufacture finished formulations like Tablets, Capsules, Syrups, Suspensions, Injections, Cream, Lotions etc.
-
Independent QA department equipped with sophisticated instruments & well trained personnel who ensure high standards
Research & Development
Facilities
Our research centers are located in Turbhe, Navi-Mumbai & Vadodara, Gujarat which are well connected via transportation like road, train and air. We have a team of highly qualified and experienced professional scientists mainly focusing on research and development activities. Our primary focus is to provide cost effective quality medicines with better patient compliance by providing novel drug delivery systems and development of generics with non-infringing process.